Cargando…
Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy
• Seizures have been observed in epilepsy patients receiving high dose intravenous or intrathecal Methotrexate (Mtx) therapy for the treatment of leukemias, due to reduction in valproic acid (VPA) levels. • Prolonged low dose weekly Mtx exposure can also produce reduction in VPA levels causing seizu...
Autores principales: | Cherian, Ajith, Shetty, Sharath Chandra, Divya, K.P., Pavuluri, Harini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187960/ https://www.ncbi.nlm.nih.gov/pubmed/34142078 http://dx.doi.org/10.1016/j.ebr.2021.100457 |
Ejemplares similares
-
The Dysfunctional Gangway: SZT2-associated Epilepsy with Thick Corpus Callosum
por: Cherian, Ajith, et al.
Publicado: (2021) -
Epilepsy in Pregnancy—Management Principles and Focus on Valproate
por: Błaszczyk, Barbara, et al.
Publicado: (2022) -
Comparison of the Metabolic Syndrome Risk in Valproate-Treated Patients with Epilepsy and the General Population in Estonia
por: Rakitin, Aleksei, et al.
Publicado: (2014) -
Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy
por: Banawalikar, N., et al.
Publicado: (2021) -
Alterations in semen parameters in men wıth epilepsy treated with valproate
por: Kose-Ozlece, Hatice, et al.
Publicado: (2015)